BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9466481)

  • 1. Hematopoietic growth factors in the treatment of acute leukemia.
    Estey E
    Curr Opin Oncol; 1998 Jan; 10(1):23-30. PubMed ID: 9466481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of cytokines in the treatment of acute myelocytic leukemia: a critical review.
    Geller RB
    J Clin Oncol; 1996 Apr; 14(4):1371-82. PubMed ID: 8648396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor in the treatment of acute myeloid leukemia and acute lymphoblastic leukemia.
    Ohno R
    Leuk Res; 1998 Dec; 22(12):1143-54. PubMed ID: 9922078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocytic colony-stimulating factors (G-CSF and GM-CSF) in the treatment of adult acute myeloid leukemia.
    Dombret H; Toubert ME; Schlageter MH; Chomienne C; Degos L
    Nouv Rev Fr Hematol (1978); 1991; 33(6):445-8. PubMed ID: 1726333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B.
    Stone RM; Berg DT; George SL; Dodge RK; Paciucci PA; Schulman P; Lee EJ; Moore JO; Powell BL; Schiffer CA
    N Engl J Med; 1995 Jun; 332(25):1671-7. PubMed ID: 7760868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocytic colony-stimulating factors in the management of patients with acute myeloid leukemia.
    Dombret H
    Hematol Cell Ther; 1996 Jul; 38(3):231-40. PubMed ID: 8974786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia.
    Löwenberg B; Boogaerts MA; Daenen SM; Verhoef GE; Hagenbeek A; Vellenga E; Ossenkoppele GJ; Huijgens PC; Verdonck LF; van der Lelie J; Wielenga JJ; Schouten HC; Gmür J; Gratwohl A; Hess U; Fey MF; van Putten WL
    J Clin Oncol; 1997 Dec; 15(12):3496-506. PubMed ID: 9396403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colony-stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemia.
    Gurion R; Belnik-Plitman Y; Gafter-Gvili A; Paul M; Vidal L; Ben-Bassat I; Shpilberg O; Raanani P
    Cochrane Database Syst Rev; 2011 Sep; (9):CD008238. PubMed ID: 21901718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the treatment of myeloid leukemia.
    Hoelzer D; Seipelt G
    Curr Opin Hematol; 1995 May; 2(3):196-203. PubMed ID: 9371995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.
    Zittoun R; Suciu S; Mandelli F; de Witte T; Thaler J; Stryckmans P; Hayat M; Peetermans M; Cadiou M; Solbu G; Petti MC; Willemze R
    J Clin Oncol; 1996 Jul; 14(7):2150-9. PubMed ID: 8683249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
    Lemoli RM; Gulati SC; Strife A; Lambek C; Perez A; Clarkson BD
    Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monocyte-macrophages, granulocyte-macrophage colony-stimulating factor, and prolonged survival among patients with acute myeloid leukemia and stem cell transplants.
    Giles FJ
    Clin Infect Dis; 1998 Jun; 26(6):1282-9. PubMed ID: 9636847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colony-stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemia.
    Gurion R; Belnik-Plitman Y; Gafter-Gvili A; Paul M; Vidal L; Ben-Bassat I; Shpilberg O; Raanani P
    Cochrane Database Syst Rev; 2012 Jun; 2012(6):CD008238. PubMed ID: 22696376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
    J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost analyses of adjunct colony stimulating factors for acute leukemia: can they improve clinical decision making.
    Bennett CL; Stinson TJ; Laver JH; Bishop MR; Godwin JE; Tallman MS
    Leuk Lymphoma; 2000 Mar; 37(1-2):65-70. PubMed ID: 10721770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact on acute myeloid leukemia relapse in granulocyte colony-stimulating factor application: a meta-analysis.
    Feng X; Lan H; Ruan Y; Li C
    Hematology; 2018 Oct; 23(9):581-589. PubMed ID: 29516766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of GM-CSF and G-CSF in the treatment of acute leukemias.
    Harousseau JL; Wu D
    Leuk Lymphoma; 1995 Aug; 18(5-6):405-12. PubMed ID: 8528046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of granulocyte and granulocyte-macrophage colony-stimulating factors in the induction treatment of adult acute lymphoblastic leukemia: a multicenter randomized study.
    Thomas X; Boiron JM; Huguet F; Reman O; Sutton L; Turlure P; Garban F; Gardin C; Espinouse D; Boulat O; Lhéritier V; Fiere D;
    Hematol J; 2004; 5(5):384-94. PubMed ID: 15448664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New perspectives in the treatment of acute myeloid leukemia by hematopoietic growth factors.
    Hiddemann W; Wörmann B; Reuter C; Schleyer E; Zühlsdorf M; Böckmann A; Büchner T
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):33-8. PubMed ID: 7528449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.